The Study of Efficacy and Safety of Dimephosphon® in Acute Ischemic Stroke
A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 184 participants.
Also called NCT07167550
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 184 participants
- Sponsor
- Tatchempharmpreparaty, JSC
- Registry
-
NCT07167550
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Russia
- Registry status
- Recruiting
Technical summary
Registry record NCT07167550. Randomized; double masking; primary purpose treatment. Start 2025-09-06 (anticipated); primary completion 2026-01-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The Study of Efficacy and Safety of Dimephosphon® in Acute Ischemic Stroke
- Condition
- Stroke
- Condition
- Acute Stroke
- Condition
- Ischemic Stroke
- Condition
- Cerebrovascular Disorders
- Condition
- Physiological Effects of Drugs
- Intervention (Drug)
- Dimephosphon®
- Intervention (Drug)
- Placebo
- Lead sponsor
- Tatchempharmpreparaty, JSC
Record details
- Record id
cardio:ct-nct07167550- Content hash
9cd4b6127a4eeec542bb27d04c8d3288d4af3a50c3ddcfee9e7bdaf4ddcf4d80